Arcadia Biosciences Inc (RKDA)
3.17
+0.06
(+1.77%)
USD |
NASDAQ |
Jun 28, 16:00
3.17
0.00 (0.00%)
After-Hours: 20:00
Arcadia Biosciences SG&A Expense (Annual): 14.51M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.51M |
| December 31, 2022 | 15.04M |
| December 31, 2021 | 22.94M |
| December 31, 2020 | 16.47M |
| December 31, 2019 | 13.57M |
| December 31, 2018 | 11.60M |
| Date | Value |
|---|---|
| December 31, 2017 | 10.65M |
| December 31, 2016 | 12.25M |
| December 31, 2015 | 11.12M |
| December 31, 2014 | 10.13M |
| December 31, 2013 | 7.967M |
| December 31, 2012 | 8.283M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
13.57M
Minimum
2019
22.94M
Maximum
2021
16.50M
Average
15.04M
Median
2022
SG&A Expense (Annual) Benchmarks
| Better Choice Co Inc | 24.44M |
| Laird Superfood Inc | 20.79M |
| Acme United Corp | 59.02M |
| Bridgford Foods Corp | 63.98M |
| The Hain Celestial Group Inc | 289.23M |